+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • May 2024
  • 54 Pages
  • Global
From
Osteoporosis: Epidemiology Forecast to 2033 - Product Thumbnail Image

Osteoporosis: Epidemiology Forecast to 2033

  • Report
  • May 2024
  • 41 Pages
  • Global
From
Spinal Muscular Atrophy: Opportunity Assessment and Forecast 2023-2033 - Product Thumbnail Image

Spinal Muscular Atrophy: Opportunity Assessment and Forecast 2023-2033

  • Report
  • May 2024
  • 64 Pages
  • Global
From
Osteoporosis: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Osteoporosis: 68-Market Analysis and Sales Forecast

  • Report
  • May 2024
  • 16 Pages
  • Global
From
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast

  • Report
  • May 2024
  • 16 Pages
  • Global
From
Psychedelics Therapeutics Development and Trends, 2024 - Product Thumbnail Image

Psychedelics Therapeutics Development and Trends, 2024

  • Report
  • April 2024
  • 36 Pages
  • Global
From
Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • March 2024
  • 397 Pages
  • Global
From
Rare Disease ?Pipeline Analysis ?Landscape in 2023 - Product Thumbnail Image

Rare Disease ?Pipeline Analysis ?Landscape in 2023

  • Drug Pipelines
  • February 2024
  • 29 Pages
  • Global
From
Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 83 Pages
  • Global
From
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (Her2- Breast Cancer) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (Her2- Breast Cancer) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 1264 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 595 Pages
  • Global
From
Major Depressive Disorder: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Major Depressive Disorder: 68-Market Analysis and Sales Forecast

  • Report
  • January 2024
  • 17 Pages
  • Global
From
Hyperinsulinemia (HI) - Competitive Landscape - Product Thumbnail Image

Hyperinsulinemia (HI) - Competitive Landscape

  • Report
  • January 2024
  • 69 Pages
  • Global
From
Acute Ischemic Stroke (AIS) - Competitive Landscape - Product Thumbnail Image

Acute Ischemic Stroke (AIS) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 100 Pages
  • Global
From
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • October 2023
  • 68 Pages
  • Global
From
Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • October 2023
  • 105 Pages
  • Global
From
Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • October 2023
  • 431 Pages
  • Global
From
Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2023
  • 70 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032

  • Report
  • October 2023
  • 38 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more